DK2954894T3 - Stabilt og lyofiliseret farmaceutisk middel indeholdende nocathiacin - Google Patents
Stabilt og lyofiliseret farmaceutisk middel indeholdende nocathiacin Download PDFInfo
- Publication number
- DK2954894T3 DK2954894T3 DK13874294.5T DK13874294T DK2954894T3 DK 2954894 T3 DK2954894 T3 DK 2954894T3 DK 13874294 T DK13874294 T DK 13874294T DK 2954894 T3 DK2954894 T3 DK 2954894T3
- Authority
- DK
- Denmark
- Prior art keywords
- lyofilized
- stable
- pharmaceutical composition
- composition containing
- containing nocathiacin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inorganic Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100448189A CN103040769A (zh) | 2013-02-05 | 2013-02-05 | 一种稳定的诺卡沙星粉针冻干剂 |
| PCT/CN2013/083366 WO2014121611A1 (zh) | 2013-02-05 | 2013-09-12 | 一种稳定的诺卡沙星粉针冻干剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2954894T3 true DK2954894T3 (da) | 2019-08-26 |
Family
ID=48053782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13874294.5T DK2954894T3 (da) | 2013-02-05 | 2013-09-12 | Stabilt og lyofiliseret farmaceutisk middel indeholdende nocathiacin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9616125B2 (da) |
| EP (1) | EP2954894B1 (da) |
| JP (1) | JP6063064B2 (da) |
| KR (1) | KR101801177B1 (da) |
| CN (1) | CN103040769A (da) |
| AU (1) | AU2013377601B2 (da) |
| CA (1) | CA2900114C (da) |
| DK (1) | DK2954894T3 (da) |
| ES (1) | ES2749474T3 (da) |
| RU (1) | RU2015137828A (da) |
| WO (1) | WO2014121611A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103040769A (zh) * | 2013-02-05 | 2013-04-17 | 南京碧迪可医药科技有限公司 | 一种稳定的诺卡沙星粉针冻干剂 |
| CN104771359A (zh) * | 2015-04-02 | 2015-07-15 | 南京正大天晴制药有限公司 | 一种稳定的盐酸莫西沙星注射液 |
| CN107469068B (zh) * | 2017-08-04 | 2021-06-22 | 南京碧迪可医药科技有限公司 | 一种硫肽环素的药物组合物 |
| KR20230141971A (ko) * | 2022-03-24 | 2023-10-10 | 주식회사 엘지화학 | 이소옥사졸린 유도체를 포함하는 주사용 제제 및 이의 제조방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020055465A1 (en) * | 2000-08-14 | 2002-05-09 | Wenying Li | Nocathiacin antibiotics prepared by biotransformation or chemical methods |
| AU2003230908A1 (en) * | 2002-04-11 | 2003-10-27 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| US20080132500A1 (en) * | 2006-10-20 | 2008-06-05 | Kun Liu | Antibiotic compounds |
| GB0821806D0 (en) * | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| DK2525830T3 (da) * | 2010-01-22 | 2016-08-15 | Ascendis Pharma As | Dipeptid-baserede prodrug-linkere til alifatiske amin-indeholdende lægemidler |
| CN102018953B (zh) * | 2010-11-18 | 2013-05-01 | 南京碧迪可医药科技有限公司 | 含诺卡沙星抗生素的药物组合物 |
| CN103040769A (zh) * | 2013-02-05 | 2013-04-17 | 南京碧迪可医药科技有限公司 | 一种稳定的诺卡沙星粉针冻干剂 |
| CN103040770B (zh) * | 2013-02-05 | 2016-08-17 | 南京碧迪可医药科技有限公司 | 一种诺卡沙星冻干粉针剂的制备方法 |
-
2013
- 2013-02-05 CN CN2013100448189A patent/CN103040769A/zh active Pending
- 2013-09-12 WO PCT/CN2013/083366 patent/WO2014121611A1/zh active Application Filing
- 2013-09-12 DK DK13874294.5T patent/DK2954894T3/da active
- 2013-09-12 EP EP13874294.5A patent/EP2954894B1/en not_active Not-in-force
- 2013-09-12 ES ES13874294T patent/ES2749474T3/es active Active
- 2013-09-12 CA CA2900114A patent/CA2900114C/en not_active Expired - Fee Related
- 2013-09-12 AU AU2013377601A patent/AU2013377601B2/en not_active Ceased
- 2013-09-12 JP JP2015556371A patent/JP6063064B2/ja not_active Expired - Fee Related
- 2013-09-12 US US14/765,375 patent/US9616125B2/en active Active
- 2013-09-12 KR KR1020157024023A patent/KR101801177B1/ko active IP Right Grant
- 2013-09-12 RU RU2015137828A patent/RU2015137828A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015137828A (ru) | 2017-03-10 |
| CN103040769A (zh) | 2013-04-17 |
| EP2954894A1 (en) | 2015-12-16 |
| KR20150113201A (ko) | 2015-10-07 |
| CA2900114C (en) | 2017-06-13 |
| EP2954894A4 (en) | 2016-06-15 |
| KR101801177B1 (ko) | 2017-11-24 |
| US20150374824A1 (en) | 2015-12-31 |
| AU2013377601B2 (en) | 2017-02-02 |
| EP2954894B1 (en) | 2019-08-14 |
| CA2900114A1 (en) | 2014-08-14 |
| WO2014121611A1 (zh) | 2014-08-14 |
| JP2016507535A (ja) | 2016-03-10 |
| JP6063064B2 (ja) | 2017-01-18 |
| US9616125B2 (en) | 2017-04-11 |
| AU2013377601A1 (en) | 2015-08-27 |
| ES2749474T3 (es) | 2020-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK3043784T3 (da) | Arylethere og anvendelser deraf | |
| IL240290A0 (en) | History of pyridazinone-amide and pharmaceutical preparations containing them | |
| DK2968443T3 (da) | Hepcidinanaloger og anvendelser deraf | |
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK2963056T3 (da) | Insulinanalog og anvendelse deraf | |
| DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK3003039T3 (da) | Methyl/fluor-pyridinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser og fluor-pyrimidinyl-metoxy-substituerede pyridinon-pyridinyl-forbindelser | |
| DK2968173T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK2962100T3 (da) | Tuberkulosebiomarkører og anvendelser deraf | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3043778T3 (da) | Farmaceutiske sammensætninger, der indeholder refametinib | |
| DK3011041T3 (da) | Biodieselsammensætning og dermed forbundet fremgangsmåde og produkter | |
| DK3029038T3 (da) | Tetrazolinonforbindelse og anvendelse deraf | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| DK2968063T3 (da) | Holder og adapter til medikamentbeholder | |
| DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
| DK3058936T3 (da) | Peptidsammensætning og anvendelser deraf | |
| DK2988733T3 (da) | Farmaceutisk sammensætning indeholdende krystallin macitentan | |
| DK3064491T3 (da) | Sulfonamidderivat og medicinsk anvendelse deraf | |
| EP2995308A4 (en) | ANTI-HYPOXIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| DK3066089T3 (da) | Substituerede n-acetyl-l-cysteinderivater og relaterede forbindelser |